Shan Wu
Corporate Officer/Principal at VIRIDIAN THERAPEUTICS, INC.
Profile
Shan Wu is currently the Chief Business Officer at Viridian Therapeutics, Inc. Prior to this role, she served as the Vice President & Head of Business Development at Magenta Therapeutics, Inc. from 2021 to 2023.
Dr. Wu completed her undergraduate degree at the University of Virginia and holds a doctorate from the Massachusetts Institute of Technology.
Shan Wu active positions
| Companies | Position | Start |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 30/10/2023 |
Former positions of Shan Wu
| Companies | Position | End |
|---|---|---|
| MAGENTA THERAPEUTICS | Investor Relations Contact | 01/09/2023 |
Training of Shan Wu
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Virginia | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Shan Wu